Curaleaf (OTCMKTS:CURLF) Shares Up 4.8% – Should You Buy?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) traded up 4.8% on Friday . The company traded as high as $9.81 and last traded at $9.81. 127,836 shares changed hands during mid-day trading, a decline of 58% from the average session volume of 301,936 shares. The stock had previously closed at $9.36.

Analyst Ratings Changes

Several equities analysts recently issued reports on CURLF shares. Zacks Research upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 14th. Citigroup reaffirmed a “buy” rating on shares of Curaleaf in a research note on Thursday, August 6th. Three research analysts have rated the stock with a Strong Buy rating and two have issued a Buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Strong Buy”.

Curaleaf Stock Performance

The business’s fifty day simple moving average is $8.10 and its 200-day simple moving average is $7.94. The firm has a market cap of $2.29 billion, a P/E ratio of -75.45 and a beta of 1.56. The company has a current ratio of 1.52, a quick ratio of 0.73 and a debt-to-equity ratio of 1.06.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of ($0.20) by $0.25. The firm had revenue of $340.10 million during the quarter, compared to the consensus estimate of $332.00 million. Curaleaf had a negative net margin of 2.62% and a negative return on equity of 0.88%. As a group, sell-side analysts expect that Curaleaf Holdings, Inc. will post 0.01 earnings per share for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.